Drug Shortage Report for MEPRON

Last updated on 2021-04-22 History
Report ID 137630
Drug Identification Number 02217422
Brand name MEPRON
Common or Proper name Atovaquone Oral Suspension
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) ATOVAQUONE
Strength(s) 750MG
Dosage form(s) SUSPENSION
Route of administration ORAL ORAL
Packaging size 210ML
ATC code P01AX
ATC description AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS.
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-04-13
Estimated end date 2021-04-26
Actual end date 2021-04-21
Shortage status Resolved
Updated date 2021-04-22
Company comments For emergency supply, contact GSK Customer Service 1-800-387-7374.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-04-22 English Compare
v4 2021-04-21 French Compare
v3 2021-04-21 English Compare
v2 2021-04-16 French Compare
v1 2021-04-16 English Compare